PapersPMID:34204220
Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction.
- findings
- 4
- compound
- 1
- endpoints
- 4
What moved
How to read these marks →“The results showed that administration of astaxanthin significantly decreased the production of TNF-α, IL-6, and IL-10.”
- Decreases interleukin-6 concentration
very limited
- Study
- animal · not in humans
- Population
- LPS-challenged C57BL/6 mice, serum cytokines measured by ELISA 4 h after LPS injection
- Study
- animal · not in humans
- Population
- LPS-challenged C57BL/6 mice, serum cytokines measured by ELISA 4 h after LPS injection
- Activates NFE2L2
very limited
“As shown in Figure 8A–D, treatment of LPS-induced DCs with astaxanthin, HO-1, and Nrf2 were significantly upregulated, compared with the LPS-only group.”
- Study
- in vitro · not in humans
- Population
- LPS-induced murine bone-marrow-derived dendritic cells
- Inhibits CCR7
very limited
“With LPS treatment alone, CCR7 expression was significantly increased, whereas they remarkably declined after the treatment of astaxanthin.”
- Study
- in vitro · not in humans
- Population
- LPS-induced murine bone-marrow-derived dendritic cells
Study record
- Design
- animal study, in vivo
- Species
- mixed
- Population
- Murine bone-marrow-derived dendritic cells (from C57BL/6 mice) treated with LPS in vitro; and LPS-challenged male C57BL/6 mice in vivo
- Participants
- not reported
- Comparator
- not stated in the paper / placebo
- Duration
- not reported
- Endpoints measured
- 14
astaxanthin